Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of therapeutic targets of the hijacked super-enhancer complex in EVI1-rearranged leukemia
Sandra Kiehlmeier, Mahmoud‐Reza Rafiee, Ali Bakr, et al.
Leukemia (2021) Vol. 35, Iss. 11, pp. 3127-3138
Open Access | Times Cited: 20

Showing 20 citing articles:

Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia
Maria R. Baer, Aksinija A. Kogan, Søren M. Bentzen, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 7, pp. 1313-1322
Open Access | Times Cited: 39
EVI1 drives leukemogenesis through aberrant ERG activation
Johannes Schmoellerl, Inês Amorim Monteiro Barbosa, Martina Minnich, et al.
Blood (2022) Vol. 141, Iss. 5, pp. 453-466
Closed Access | Times Cited: 25
Super-Enhancers and Their Parts: From Prediction Efforts to Pathognomonic Status
Anastasia V. Vasileva, Marina G. Gladkova, German A. Ashniev, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3103-3103
Open Access | Times Cited: 6
Proteomics appending a complementary dimension to precision oncotherapy
Zhaokai Zhou, Ruiqi Zhang, Aoyang Zhou, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 1725-1739
Open Access | Times Cited: 4
Significance of Somatic Mutation Profiling in CML Beyond BCR-ABL: A Retrospective Study of the Indian Population
Pooja Chaudhary, Spandan Chaudhary, Falguni Patel, et al.
Indian Journal of Hematology and Blood Transfusion (2024) Vol. 41, Iss. 1, pp. 10-22
Closed Access | Times Cited: 3
Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies
Sonia Dębek, Przemysław Juszczyński
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 2, pp. 188697-188697
Closed Access | Times Cited: 13
3q26.2/MECOM Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features
Zhenya Tang, Wei Wang, Su Yang, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 458-458
Open Access | Times Cited: 6
TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression
Elizabeth Heyes, Anna S. Wilhelmson, Anne Wenzel, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
GATA2 deficiency elevates interferon regulatory factor-8 to subvert a progenitor cell differentiation program
Kirby D. Johnson, Alexandra A. Soukup, Emery H. Bresnick
Blood Advances (2022) Vol. 6, Iss. 5, pp. 1464-1473
Open Access | Times Cited: 9
Cracking chromatin with proteomics: From chromatome to histone modifications
Gianluca Sigismondo, Dimitris Papageorgiou, Jeroen Krijgsveld
PROTEOMICS (2022) Vol. 22, Iss. 15-16
Open Access | Times Cited: 9
Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites
Eros Di Giorgio, Roberta Benetti, Emanuela Kerschbamer, et al.
International review of cell and molecular biology (2023), pp. 97-148
Closed Access | Times Cited: 5
Super enhancers: Pathogenic roles and potential therapeutic targets for acute myeloid leukemia (AML)
Ziyang Cao, Yi Shu, Jinxia Wang, et al.
Genes & Diseases (2022) Vol. 9, Iss. 6, pp. 1466-1477
Open Access | Times Cited: 8
Impact of Next-Generation Sequencing in Diagnosis, Prognosis and Therapeutic Management of Acute Myeloid Leukemia/Myelodysplastic Neoplasms
Lamia Madaci, Laure Farnault, Norman Abbou, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3280-3280
Open Access | Times Cited: 4
High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma
Paul Jank, Jonas Leichsenring, Svenja Kolb, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Trending Drugs Combination to Target Leukemia associated Proteins/Genes: using Graph Neural Networks under the RAIN Protocol
Mahnaz Boush, Ali Akbar Kiaei, Hossein Mahboubi
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
EVI1-mediated Programming of Normal and Malignant Hematopoiesis
Susanne Lux, Michael D. Milsom
HemaSphere (2023) Vol. 7, Iss. 10, pp. e959-e959
Open Access | Times Cited: 4
Super-enhancer omics in stem cell
Hongying Ma, Jian Qu, Zicheng Pang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
EVI1 protein interaction dynamics: Targetable for therapeutic intervention?
Roberto Paredes, Nora Julia Doleschall, Kathleen Connors, et al.
Experimental Hematology (2021) Vol. 107, pp. 1-8
Open Access | Times Cited: 6
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML
Matteo Marchesini, Andrea Gherli, Elisa Simoncini, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
TET2lesions enhance the aggressiveness ofCEBPA-mutant AML by rebalancingGATA2expression
Elizabeth Heyes, Anna S. Wilhelmson, Anne Wenzel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top